{"nctId":"NCT01763905","briefTitle":"Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2","startDateStruct":{"date":"2013-01-24","type":"ACTUAL"},"conditions":["Hyperlipidemia"],"count":307,"armGroups":[{"label":"Ezetimibe (Q2W)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Placebo to Evolocumab","Drug: Ezetimibe"]},{"label":"Ezetimibe (QM)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Placebo to Evolocumab","Drug: Ezetimibe"]},{"label":"Evolocumab Q2W","type":"EXPERIMENTAL","interventionNames":["Biological: Evolocumab","Drug: Placebo to Ezetimibe"]},{"label":"Evolocumab QM","type":"EXPERIMENTAL","interventionNames":["Biological: Evolocumab","Drug: Placebo to Ezetimibe"]}],"interventions":[{"name":"Evolocumab","otherNames":["AMG 145","Repatha"]},{"name":"Placebo to Evolocumab","otherNames":[]},{"name":"Ezetimibe","otherNames":["Zetia"]},{"name":"Placebo to Ezetimibe","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female ≥ 18 to ≤ 80 years of age\n* Not on a statin or on a low dose statin with stable dose for at least 4 weeks\n* History of intolerance to at least 2 statins\n* Subject not at LDL-C goal\n* Lipid lowering therapy has been stable prior to enrolment for at least 4 weeks.\n* Fasting triglycerides ≤ 400 mg/dL\n\nExclusion Criteria:\n\n* New York Heart Association (NYHA) III or IV heart failure\n* Uncontrolled cardiac arrhythmia\n* Uncontrolled hypertension\n* Type 1 diabetes, poorly controlled type 2 diabetes\n* Uncontrolled hypothyroidism or hyperthyroidism","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change From Baseline in LDL-C at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-18.08","spread":"2.52"},{"groupId":"OG001","value":"-15.05","spread":"2.13"},{"groupId":"OG002","value":"-56.14","spread":"1.91"},{"groupId":"OG003","value":"-52.60","spread":"1.58"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in LDL-C at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-39.1","spread":"5.1"},{"groupId":"OG001","value":"-33.0","spread":"4.5"},{"groupId":"OG002","value":"-105.4","spread":"3.9"},{"groupId":"OG003","value":"-103.6","spread":"3.4"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in LDL-C at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-36.2","spread":"5.4"},{"groupId":"OG001","value":"-30.2","spread":"4.7"},{"groupId":"OG002","value":"-106.0","spread":"4.1"},{"groupId":"OG003","value":"-99.0","spread":"3.5"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Mean LDL-C at Weeks 10 and 12 of Less Than 70 mg/dL (1.8 mmol/L)","description":null,"paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":null},{"groupId":"OG001","value":"0.0","spread":null},{"groupId":"OG002","value":"45.5","spread":null},{"groupId":"OG003","value":"42.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With LDL-C < 70 mg/dL (1.8 mmol/L) at Week 12","description":null,"paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":null},{"groupId":"OG001","value":"0.0","spread":null},{"groupId":"OG002","value":"50.0","spread":null},{"groupId":"OG003","value":"37.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Non-HDL-C at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.18","spread":"2.15"},{"groupId":"OG001","value":"-14.54","spread":"1.86"},{"groupId":"OG002","value":"-48.72","spread":"1.64"},{"groupId":"OG003","value":"-49.13","spread":"1.40"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Non-HDL-C at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.53","spread":"2.30"},{"groupId":"OG001","value":"-13.16","spread":"1.93"},{"groupId":"OG002","value":"-48.62","spread":"1.74"},{"groupId":"OG003","value":"-46.15","spread":"1.43"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.67","spread":"2.15"},{"groupId":"OG001","value":"-11.02","spread":"2.21"},{"groupId":"OG002","value":"-45.88","spread":"1.68"},{"groupId":"OG003","value":"-46.01","spread":"1.65"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.95","spread":"2.32"},{"groupId":"OG001","value":"-9.97","spread":"2.34"},{"groupId":"OG002","value":"-45.81","spread":"1.79"},{"groupId":"OG003","value":"-43.07","spread":"1.73"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in the Total Cholesterol/High Density Lipoprotein Cholesterol Ratio at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.44","spread":"2.14"},{"groupId":"OG001","value":"-11.20","spread":"2.16"},{"groupId":"OG002","value":"-40.83","spread":"1.65"},{"groupId":"OG003","value":"-41.14","spread":"1.62"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in the Total Cholesterol/High Density Lipoprotein Cholesterol Ratio at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.13","spread":"2.30"},{"groupId":"OG001","value":"-9.92","spread":"2.34"},{"groupId":"OG002","value":"-40.42","spread":"1.75"},{"groupId":"OG003","value":"-38.57","spread":"1.73"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B/Apolipoprotein A1 Ratio at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.00","spread":"2.27"},{"groupId":"OG001","value":"-11.94","spread":"2.56"},{"groupId":"OG002","value":"-47.86","spread":"1.77"},{"groupId":"OG003","value":"-48.31","spread":"1.92"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B/Apolipoprotein A1 Ratio at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.14","spread":"2.47"},{"groupId":"OG001","value":"-11.37","spread":"2.71"},{"groupId":"OG002","value":"-47.66","spread":"1.90"},{"groupId":"OG003","value":"-45.51","spread":"2.01"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lipoprotein (a) at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.30","spread":"3.36"},{"groupId":"OG001","value":"1.55","spread":"4.01"},{"groupId":"OG002","value":"-26.20","spread":"2.64"},{"groupId":"OG003","value":"-23.72","spread":"2.97"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lipoprotein (a) at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.74","spread":"3.58"},{"groupId":"OG001","value":"5.81","spread":"5.10"},{"groupId":"OG002","value":"-27.03","spread":"2.78"},{"groupId":"OG003","value":"-22.07","spread":"3.66"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Triglycerides at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.74","spread":"3.88"},{"groupId":"OG001","value":"-0.32","spread":"4.65"},{"groupId":"OG002","value":"-6.32","spread":"2.94"},{"groupId":"OG003","value":"-6.73","spread":"3.44"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Triglycerides at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.47","spread":"4.25"},{"groupId":"OG001","value":"2.16","spread":"5.52"},{"groupId":"OG002","value":"-3.88","spread":"3.18"},{"groupId":"OG003","value":"-2.53","spread":"3.98"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in High-Density Lipoprotein Cholesterol (HDL-C) at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.33","spread":"1.98"},{"groupId":"OG001","value":"1.44","spread":"2.03"},{"groupId":"OG002","value":"5.48","spread":"1.51"},{"groupId":"OG003","value":"7.18","spread":"1.51"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in High-Density Lipoprotein Cholesterol (HDL-C) at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.77","spread":"2.22"},{"groupId":"OG001","value":"1.64","spread":"2.22"},{"groupId":"OG002","value":"5.34","spread":"1.67"},{"groupId":"OG003","value":"6.47","spread":"1.63"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Very Low-Density Lipoprotein Cholesterol at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.76","spread":"3.80"},{"groupId":"OG001","value":"-2.93","spread":"4.41"},{"groupId":"OG002","value":"-7.60","spread":"2.89"},{"groupId":"OG003","value":"-6.46","spread":"3.21"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Very Low-Density Lipoprotein Cholesterol at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.49","spread":"4.05"},{"groupId":"OG001","value":"-2.25","spread":"5.11"},{"groupId":"OG002","value":"-6.16","spread":"3.08"},{"groupId":"OG003","value":"-2.18","spread":"3.60"}]}]}]},{"type":"PRIMARY","title":"Percent Change From Baseline in LDL-C at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-19.21","spread":"2.40"},{"groupId":"OG001","value":"-16.62","spread":"2.03"},{"groupId":"OG002","value":"-56.11","spread":"1.83"},{"groupId":"OG003","value":"-55.31","spread":"1.53"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":51},"commonTop":["Myalgia","Headache","Fatigue","Muscle spasms","Nausea"]}}}